| dc.contributor.author | Silman, Daniel | |
| dc.date.accessioned | 2021-03-31T15:56:04Z | |
| dc.date.available | 2021-03-31T15:56:04Z | |
| dc.date.issued | 2020-08 | |
| dc.identifier.citation | Silman, D. (2020). How effective is augmentation with psychotherapy as a next-step option for treatment-resistant depression? BJPsych Advances, 26(5), 255-261 | en |
| dc.identifier.uri | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/761 | |
| dc.description | The article attached to this record is the Author(s) pre-/post- print version only. NOTE: this is not the version published in BJPsych Advances. Minor changes may have been made for publication.
Eligible users can access the full text via NHS OpenAthens (login required) | |
| dc.description.abstract | Determining the optimum next-step treatment for the numerous patients with depression who do not adequately respond to an initial trial of medication remains a source of uncertainty in clinical practice. Although a number of psychological treatments are known to be effective for depression, their relative merits in the treatment-resistant group have not been ascertained. The Cochrane Collaboration has recently published a meta-analysis of the evidence available for the use of various psychotherapies as an adjunct to antidepressants compared with antidepressants alone in treatment-resistant depression. This article provides a commentary and appraisal of the clinical utility of these findings. | en |
| dc.description.uri | https://doi.org/10.1192/bja.2020.51 | en |
| dc.language.iso | en | en |
| dc.subject | Psychotherapy | en |
| dc.subject | Depressive Disorders | en |
| dc.title | How effective is augmentation with psychotherapy as a next-step option for treatment-resistant depression? | en |
| dc.type | PrePrint | en |
| dc.contributor.discipline | Medical Trainee | en |